Quantitative characterization of PP2A-derived peptides modulating the LRRK2:PP2A protein-protein interaction

Abstract

Parkinson's disease (PD) is the most prevalent motor neurodegenerative disorder with currently no disease-modifying treatment. LRRK2 is a major PD genetic determinant, showing dephosphorylation of its heterologous phosphorylation sites (S910/S935) in disease. We previously proposed preventing LRRK2 S910/S935 dephosphorylation as a PD therapeutic approach attenuating LRRK2 hyperactivation. As PP2A phosphatase subunits are key regulators of this dephosphorylation, we targeted the LRRK2:PP2A protein-protein interaction (PPI) as strategy to prevent LRRK2 dephosphorylation. Using Microscale Thermophoresis, we measured the binding affinities of two PPP2CA-derived peptides, HT16 and QA16, for LRRK2, with dissociation constants ranging from 0.3 to 5 µM. Strikingly, co-incubation of both peptides showed a sevenfold improved binding affinity, suggesting two distinct but allosterically coupled binding sites on LRRK2. Co-immunoprecipitation experiments in HEK293T cells further demonstrated that these peptides compete with PPP2CA for binding to LRRK2. AlphaFold2 structural modelling identified putative PPP2CA residues at the LRRK2 interaction interface. Alanine scanning of these residues clarified their contribution to the interaction pointing to Y130, D223 and H230 of PPP2CA as potential LRRK2 binding hotspots. These results provide the first quantitative characterization of the LRRK2:PPP2CA interaction interface and establish peptide molecular tools to develop selective PPI modulators blocking LRRK2 S910/S935 dephosphorylation as PD therapeutic approach.

Interaction of elastin-derived peptides with model lipid membranes
Manon Ragouilliaux, Jean-Marc Crowet, Frank Wien +3
Biochimica et Biophysica Acta:Biomembranes15 Oct 2026Peer-reviewedCC BY 4.0Full textBiophysics General biologyHAL
Conformational, Aggregation, and Membrane Interaction Dynamics of Keratin-Derived Antimicrobial Peptides from Molecular Dynamics Simulations.
Panagiotis Panagopoulos Papageorgiou, Katerina S Karadima, Ioanna Papageorgiou +2
The journal of physical chemistry. B1 Oct 2026Peer-reviewedCC BY-NC-NDFull textMicrobiologyEurope PMC
In Silico Characterization of Desert Locust-Derived Antimicrobial Peptides Against Drug-Resistant Bacteria.
Peter M Mwangi, Lilly C Bebora, James K Gathumbi +4
Scientifica28 Oct 2026Peer-reviewedCC BYFull textMicrobiologyEurope PMCPMC
In silico assessment of barnyard millet and blue pea derived bioactive peptides against Salmonella enterica Serovar Typhi and Clostridioides difficile
Srujal Kacha, Romita Guchhait, Avani Panickar +2
Scientific Reports27 Oct 2026Peer-reviewedCC BY-NC-ND 4.0Full textMicrobiologyCrossref
Human milk-derived Limosilactobacillus reuteri improved growth performance of weaned pigs by modulating systemic immune responses and enhancing intestinal health
Hyunjin Kyoung, Sewon Ha, Kyeong Il Park +11
Journal of Animal Science4 Sep 2026Peer-reviewedPublisher termsFull textZoology & animal behaviourPMC

Cite

BibTeX RIS

BibTeX

@misc{stoup2026quantitative,
  title = {{Quantitative characterization of PP2A-derived peptides modulating the LRRK2:PP2A protein-protein interaction}},
  author = {Marie Stoup and Antonio Jesús Lara Ordóñez and Arkadiusz Szura and Liesel Mary Goveas and Patricia Melnyk and Nicolas Lebègue and Saïd Yous and Taymans Jean-Marc and Liberelle Maxime},
  howpublished = {HAL},
  year = {2026},
  month = oct,
  doi = {10.21203/rs.3.rs-11204417/v1},
  url = {https://hal.science/hal-05846739v1},
  note = {CC BY},
}

RIS

TY  - UNPB
TI  - Quantitative characterization of PP2A-derived peptides modulating the LRRK2:PP2A protein-protein interaction
AU  - Marie Stoup
AU  - Antonio Jesús Lara Ordóñez
AU  - Arkadiusz Szura
AU  - Liesel Mary Goveas
AU  - Patricia Melnyk
AU  - Nicolas Lebègue
AU  - Saïd Yous
AU  - Taymans Jean-Marc
AU  - Liberelle Maxime
PY  - 2026
DA  - 2026/10/22
PB  - HAL
DO  - 10.21203/rs.3.rs-11204417/v1
UR  - https://hal.science/hal-05846739v1
AB  - Parkinson's disease (PD) is the most prevalent motor neurodegenerative disorder with currently no disease-modifying treatment. LRRK2 is a major PD genetic determinant, showing dephosphorylation of its heterologous phosphorylation sites (S910/S935) in disease. We previously proposed preventing LRRK2 S910/S935 dephosphorylation as a PD therapeutic approach attenuating LRRK2 hyperactivation. As PP2A phosphatase subunits are key regulators of this dephosphorylation, we targeted the LRRK2:PP2A protein-protein interaction (PPI) as strategy to prevent LRRK2 dephosphorylation. Using Microscale Thermophoresis, we measured the binding affinities of two PPP2CA-derived peptides, HT16 and QA16, for LRRK2, with dissociation constants ranging from 0.3 to 5 µM. Strikingly, co-incubation of both peptides showed a sevenfold improved binding affinity, suggesting two distinct but allosterically coupled binding sites on LRRK2. Co-immunoprecipitation experiments in HEK293T cells further demonstrated that these peptides compete with PPP2CA for binding to LRRK2. AlphaFold2 structural modelling identified putative PPP2CA residues at the LRRK2 interaction interface. Alanine scanning of these residues clarified their contribution to the interaction pointing to Y130, D223 and H230 of PPP2CA as potential LRRK2 binding hotspots. These results provide the first quantitative characterization of the LRRK2:PPP2CA interaction interface and establish peptide molecular tools to develop selective PPI modulators blocking LRRK2 S910/S935 dephosphorylation as PD therapeutic approach.
ER  -

Abstract

Related

Cite